1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Kidney Cancer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Drugs Overall Market Size
2.1 Global Kidney Cancer Drugs Market Size: 2021 VS 2027
2.2 Global Kidney Cancer Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Kidney Cancer Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Kidney Cancer Drugs Players in Global Market
3.2 Top Global Kidney Cancer Drugs Companies Ranked by Revenue
3.3 Global Kidney Cancer Drugs Revenue by Companies
3.4 Global Kidney Cancer Drugs Sales by Companies
3.5 Global Kidney Cancer Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Kidney Cancer Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Kidney Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Kidney Cancer Drugs Players in Global Market
3.8.1 List of Global Tier 1 Kidney Cancer Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Kidney Cancer Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Kidney Cancer Drugs Market Size Markets, 2021 & 2027
4.1.2 Angiogenesis Inhibitors
4.1.3 mTOR Inhibitors
4.1.4 Monoclonal Antibodies
4.1.5 Cytokine Immunotherapy (IL-2)
4.2 By Type – Global Kidney Cancer Drugs Revenue & Forecasts
4.2.1 By Type – Global Kidney Cancer Drugs Revenue, 2016-2021
4.2.2 By Type – Global Kidney Cancer Drugs Revenue, 2022-2027
4.2.3 By Type – Global Kidney Cancer Drugs Revenue Market Share, 2016-2027
4.3 By Type – Global Kidney Cancer Drugs Sales & Forecasts
4.3.1 By Type – Global Kidney Cancer Drugs Sales, 2016-2021
4.3.2 By Type – Global Kidney Cancer Drugs Sales, 2022-2027
4.3.3 By Type – Global Kidney Cancer Drugs Sales Market Share, 2016-2027
4.4 By Type – Global Kidney Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Kidney Cancer Drugs Market Size, 2021 & 2027
5.1.2 Renal Cell Carcinoma (RCC)
5.1.3 Transitional Cell Carcinoma (TCC)
5.2 By Application – Global Kidney Cancer Drugs Revenue & Forecasts
5.2.1 By Application – Global Kidney Cancer Drugs Revenue, 2016-2021
5.2.2 By Application – Global Kidney Cancer Drugs Revenue, 2022-2027
5.2.3 By Application – Global Kidney Cancer Drugs Revenue Market Share, 2016-2027
5.3 By Application – Global Kidney Cancer Drugs Sales & Forecasts
5.3.1 By Application – Global Kidney Cancer Drugs Sales, 2016-2021
5.3.2 By Application – Global Kidney Cancer Drugs Sales, 2022-2027
5.3.3 By Application – Global Kidney Cancer Drugs Sales Market Share, 2016-2027
5.4 By Application – Global Kidney Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Kidney Cancer Drugs Market Size, 2021 & 2027
6.2 By Region – Global Kidney Cancer Drugs Revenue & Forecasts
6.2.1 By Region – Global Kidney Cancer Drugs Revenue, 2016-2021
6.2.2 By Region – Global Kidney Cancer Drugs Revenue, 2022-2027
6.2.3 By Region – Global Kidney Cancer Drugs Revenue Market Share, 2016-2027
6.3 By Region – Global Kidney Cancer Drugs Sales & Forecasts
6.3.1 By Region – Global Kidney Cancer Drugs Sales, 2016-2021
6.3.2 By Region – Global Kidney Cancer Drugs Sales, 2022-2027
6.3.3 By Region – Global Kidney Cancer Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Kidney Cancer Drugs Revenue, 2016-2027
6.4.2 By Country – North America Kidney Cancer Drugs Sales, 2016-2027
6.4.3 US Kidney Cancer Drugs Market Size, 2016-2027
6.4.4 Canada Kidney Cancer Drugs Market Size, 2016-2027
6.4.5 Mexico Kidney Cancer Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Kidney Cancer Drugs Revenue, 2016-2027
6.5.2 By Country – Europe Kidney Cancer Drugs Sales, 2016-2027
6.5.3 Germany Kidney Cancer Drugs Market Size, 2016-2027
6.5.4 France Kidney Cancer Drugs Market Size, 2016-2027
6.5.5 U.K. Kidney Cancer Drugs Market Size, 2016-2027
6.5.6 Italy Kidney Cancer Drugs Market Size, 2016-2027
6.5.7 Russia Kidney Cancer Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Kidney Cancer Drugs Market Size, 2016-2027
6.5.9 Benelux Kidney Cancer Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Kidney Cancer Drugs Revenue, 2016-2027
6.6.2 By Region – Asia Kidney Cancer Drugs Sales, 2016-2027
6.6.3 China Kidney Cancer Drugs Market Size, 2016-2027
6.6.4 Japan Kidney Cancer Drugs Market Size, 2016-2027
6.6.5 South Korea Kidney Cancer Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Kidney Cancer Drugs Market Size, 2016-2027
6.6.7 India Kidney Cancer Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Kidney Cancer Drugs Revenue, 2016-2027
6.7.2 By Country – South America Kidney Cancer Drugs Sales, 2016-2027
6.7.3 Brazil Kidney Cancer Drugs Market Size, 2016-2027
6.7.4 Argentina Kidney Cancer Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Kidney Cancer Drugs Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Kidney Cancer Drugs Sales, 2016-2027
6.8.3 Turkey Kidney Cancer Drugs Market Size, 2016-2027
6.8.4 Israel Kidney Cancer Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Kidney Cancer Drugs Market Size, 2016-2027
6.8.6 UAE Kidney Cancer Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Kidney Cancer Drugs Major Product Offerings
7.1.4 Bayer Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Bayer Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Kidney Cancer Drugs Major Product Offerings
7.2.4 Roche Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Kidney Cancer Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Kidney Cancer Drugs Major Product Offerings
7.4.4 Novartis Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Kidney Cancer Drugs Major Product Offerings
7.5.4 Pfizer Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Pfizer Key News
7.6 Abbott Laboratories
7.6.1 Abbott Laboratories Corporate Summary
7.6.2 Abbott Laboratories Business Overview
7.6.3 Abbott Laboratories Kidney Cancer Drugs Major Product Offerings
7.6.4 Abbott Laboratories Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Abbott Laboratories Key News
7.7 Active Biotech
7.7.1 Active Biotech Corporate Summary
7.7.2 Active Biotech Business Overview
7.7.3 Active Biotech Kidney Cancer Drugs Major Product Offerings
7.4.4 Active Biotech Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Active Biotech Key News
7.8 Amgen
7.8.1 Amgen Corporate Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Kidney Cancer Drugs Major Product Offerings
7.8.4 Amgen Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Amgen Key News
7.9 Argos Therapeutics
7.9.1 Argos Therapeutics Corporate Summary
7.9.2 Argos Therapeutics Business Overview
7.9.3 Argos Therapeutics Kidney Cancer Drugs Major Product Offerings
7.9.4 Argos Therapeutics Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Argos Therapeutics Key News
7.10 ArQule
7.10.1 ArQule Corporate Summary
7.10.2 ArQule Business Overview
7.10.3 ArQule Kidney Cancer Drugs Major Product Offerings
7.10.4 ArQule Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.10.5 ArQule Key News
7.11 AVEO Pharmaceuticals
7.11.1 AVEO Pharmaceuticals Corporate Summary
7.11.2 AVEO Pharmaceuticals Kidney Cancer Drugs Business Overview
7.11.3 AVEO Pharmaceuticals Kidney Cancer Drugs Major Product Offerings
7.11.4 AVEO Pharmaceuticals Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.11.5 AVEO Pharmaceuticals Key News
7.12 Bionomics
7.12.1 Bionomics Corporate Summary
7.12.2 Bionomics Kidney Cancer Drugs Business Overview
7.12.3 Bionomics Kidney Cancer Drugs Major Product Offerings
7.12.4 Bionomics Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Bionomics Key News
7.13 Bristol-Myers Squibb
7.13.1 Bristol-Myers Squibb Corporate Summary
7.13.2 Bristol-Myers Squibb Kidney Cancer Drugs Business Overview
7.13.3 Bristol-Myers Squibb Kidney Cancer Drugs Major Product Offerings
7.13.4 Bristol-Myers Squibb Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.13.5 Bristol-Myers Squibb Key News
7.14 Cerulean Pharma
7.14.1 Cerulean Pharma Corporate Summary
7.14.2 Cerulean Pharma Business Overview
7.14.3 Cerulean Pharma Kidney Cancer Drugs Major Product Offerings
7.14.4 Cerulean Pharma Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.14.5 Cerulean Pharma Key News
7.15 Exelixis
7.15.1 Exelixis Corporate Summary
7.15.2 Exelixis Business Overview
7.15.3 Exelixis Kidney Cancer Drugs Major Product Offerings
7.15.4 Exelixis Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.15.5 Exelixis Key News
7.16 Genentech
7.16.1 Genentech Corporate Summary
7.16.2 Genentech Business Overview
7.16.3 Genentech Kidney Cancer Drugs Major Product Offerings
7.16.4 Genentech Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.16.5 Genentech Key News
7.17 immatics biotechnologies
7.17.1 immatics biotechnologies Corporate Summary
7.17.2 immatics biotechnologies Business Overview
7.17.3 immatics biotechnologies Kidney Cancer Drugs Major Product Offerings
7.17.4 immatics biotechnologies Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.17.5 immatics biotechnologies Key News
7.18 Immunicum
7.18.1 Immunicum Corporate Summary
7.18.2 Immunicum Business Overview
7.18.3 Immunicum Kidney Cancer Drugs Major Product Offerings
7.18.4 Immunicum Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.18.5 Immunicum Key News
7.19 Ono Pharmaceutical
7.19.1 Ono Pharmaceutical Corporate Summary
7.19.2 Ono Pharmaceutical Business Overview
7.19.3 Ono Pharmaceutical Kidney Cancer Drugs Major Product Offerings
7.19.4 Ono Pharmaceutical Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.19.5 Ono Pharmaceutical Key News
7.20 Onyx Therapeutics
7.20.1 Onyx Therapeutics Corporate Summary
7.20.2 Onyx Therapeutics Business Overview
7.20.3 Onyx Therapeutics Kidney Cancer Drugs Major Product Offerings
7.20.4 Onyx Therapeutics Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.20.5 Onyx Therapeutics Key News
7.21 Oxford BioMedica
7.21.1 Oxford BioMedica Corporate Summary
7.21.2 Oxford BioMedica Business Overview
7.21.3 Oxford BioMedica Kidney Cancer Drugs Major Product Offerings
7.21.4 Oxford BioMedica Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.21.5 Oxford BioMedica Key News
7.22 Prometheus Laboratories
7.22.1 Prometheus Laboratories Corporate Summary
7.22.2 Prometheus Laboratories Business Overview
7.22.3 Prometheus Laboratories Kidney Cancer Drugs Major Product Offerings
7.22.4 Prometheus Laboratories Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.22.5 Prometheus Laboratories Key News
7.23 Seattle Genetics
7.23.1 Seattle Genetics Corporate Summary
7.23.2 Seattle Genetics Business Overview
7.23.3 Seattle Genetics Kidney Cancer Drugs Major Product Offerings
7.23.4 Seattle Genetics Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.23.5 Seattle Genetics Key News
7.24 Taiwan Liposome
7.24.1 Taiwan Liposome Corporate Summary
7.24.2 Taiwan Liposome Business Overview
7.24.3 Taiwan Liposome Kidney Cancer Drugs Major Product Offerings
7.24.4 Taiwan Liposome Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.24.5 Taiwan Liposome Key News
7.25 Tracon Pharmaceuticals
7.25.1 Tracon Pharmaceuticals Corporate Summary
7.25.2 Tracon Pharmaceuticals Business Overview
7.25.3 Tracon Pharmaceuticals Kidney Cancer Drugs Major Product Offerings
7.25.4 Tracon Pharmaceuticals Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.25.5 Tracon Pharmaceuticals Key News
7.26 Wilex
7.26.1 Wilex Corporate Summary
7.26.2 Wilex Business Overview
7.26.3 Wilex Kidney Cancer Drugs Major Product Offerings
7.26.4 Wilex Kidney Cancer Drugs Sales and Revenue in Global (2016-2021)
7.26.5 Wilex Key News
8 Global Kidney Cancer Drugs Production Capacity, Analysis
8.1 Global Kidney Cancer Drugs Production Capacity, 2016-2027
8.2 Kidney Cancer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Kidney Cancer Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Kidney Cancer Drugs Supply Chain Analysis
10.1 Kidney Cancer Drugs Industry Value Chain
10.2 Kidney Cancer Drugs Upstream Market
10.3 Kidney Cancer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Kidney Cancer Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
【免責事項】
http://www.globalresearch.jp/disclaimer